07076
聚氧乙烯氢化蓖麻油
别名:
PEG-40蓖麻油, 氢化蓖麻油® RH 40, 聚乙二醇甘油羟基硬脂酸酯, 聚氧乙烯40氢化蓖麻油
impurities
≤0.2% sulfated ash (verfied on random samples only), ≤1 ppm ethylene oxide, ≤10 ppm dioxan, ≤10 ppm heavy metals (verfied on random samples only), ≤2 ppm arsenic (verfied on random samples only), ≤2.0% water, ≤5000 ppm acetic acid, ≤620 ppm diethylene glycol, ≤620 ppm ethylene glycol
ign. residue
≤0.25% (verfied onrandom samples only)
acid value
≤0.8 mg KOH/g
hydroxyl value
60‑75 mg KOH/g
iodine value
≤1.0 g I2/100 g
saponification value
50‑60 mg KOH/g
suitability
suitable for acidity or alkalinity
Quality Level
Application
聚氧乙烯氢化蓖麻油可用于溶解维生素、水不溶性活性物质、以及溶于水或水和醇混合物的精油。
Analysis Note
凝固温度16-26°C
Other Notes
聚氧乙烯氢化蓖麻油是一系列非离子聚乙氧基化去污剂的品牌名称。它被开发用作增溶剂和乳化剂。
Legal Information
Cremophor is a registered trademark of BASF SE
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
467.6 °F
flash_point_c
242 °C
法规信息
植物油/植物胶产品
此项目有
Christofori M R R Nastiti et al.
Pharmaceutics, 12(2) (2020-02-06)
Resveratrol (RSV) is a potent lipophilic antioxidant with a low aqueous solubility. Novel nanoformulations have been successfully developed and evaluated to increase the potential of resveratrol as a skin targeting antioxidant. Nanoformulations were prepared using a spontaneous emulsification method, and
Masafumi Uematsu et al.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 27(5), 437-444 (2011-07-01)
To determine the element that modulates benzalkonium chloride (BAC) toxicity by using a new electrophysiological method to evaluate acute corneal barrier dysfunction induced by travoprost Z with sofZia (Travatan Z(®)), travoprost with 0.015% BAC (Travatan(®)), and its additives. Corneal transepithelial
Shoukath M Ali et al.
International immunopharmacology, 10(3), 325-330 (2009-12-23)
Develop Nanosomal formulation of Tacrolimus to provide safer alternative treatment for organ transplantation patients. Investigate safety, tolerability and pharmacokinetics of Nanosomal Tacrolimus formulation versus marketed Tacrolimus containing polyoxyl 60 hydrogenated castor oil (HCO-60) that causes side effects. Nanosomal Tacrolimus was
Yun-Seok Rhee et al.
Archives of pharmacal research, 30(1), 114-123 (2007-03-03)
The aim of this study was to develop an aqueous parenteral formulation containing itraconazole (ITZ) using an o/w microemulsion system. A mixture of benzyl alcohol and medium chain triglyceride (3/1) was chosen as the oil phase. Pseudoternary phase diagrams of
Allergic contact dermatitis to polyethylene glycol-7 hydrogenated castor oil.
M Kalavala et al.
Contact dermatitis, 56(5), 287-288 (2007-04-20)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持